{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:07:34Z","timestamp":1746158854714,"version":"3.40.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005075","name":"University Medical Centre Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nucmedbio.2024.108985","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T17:04:55Z","timestamp":1733331895000},"page":"108985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["PET imaging of the anticancer drug candidate [11C]trimebutine in a rat glioma model"],"prefix":"10.1016","volume":"142-143","author":[{"given":"Jia-zhe","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kominia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Doorduin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik F.J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108985_bb0005","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s12035-022-03171-0","article-title":"Par6 enhances glioma invasion by activating MEK\/ERK pathway through a LIN28\/let-7d positive feedback loop","volume":"60","author":"Huang","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0010","first-page":"7","article-title":"Temozolomide and other alkylating agents in glioblastoma therapy","author":"Strobel","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0015","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0020","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.812270","article-title":"PET molecular imaging in drug development: the imaging and chemistry perspective","volume":"9","author":"Nerella","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2125.2011.04085.x","article-title":"Positron emission tomography molecular imaging for drug development","volume":"73","author":"Matthews","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0035","first-page":"10","article-title":"Repositioning trimebutine maleate as a cancer treatment targeting ovarian cancer stem cells","author":"Lee","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0040","first-page":"298","article-title":"Mode of action of trimebutine: involvement if opioid receptors","volume":"18","author":"Pascaud","year":"1989","journal-title":"Presse Med"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3389\/fphar.2018.00664","article-title":"Trimebutine promotes glioma cell apoptosis as a potential anti-tumor agent","volume":"9","author":"Fan","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0050","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4161\/cc.28493","article-title":"Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma","volume":"13","author":"Friesen","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0022-3565(24)38026-7","article-title":"Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor","volume":"288","author":"Remmers","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3565(24)37088-0","article-title":"Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor","volume":"283","author":"Clark","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/10799893.2014.975246","article-title":"Controversial effect on Erk activation of some cytotoxic drugs in human LOVO colon cancer cells","volume":"36","author":"Jemel-Oualha","year":"2016","journal-title":"J Recept Signal Transduct"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood-brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0075","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399411001888","article-title":"Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain","volume":"13","author":"Agarwal","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.wneu.2018.04.022","article-title":"Challenges in the treatment of glioblastoma: multisystem mechanisms of therapeutic resistance","volume":"116","author":"Noch","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0085","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2015.1129476","article-title":"Blood brain barrier: an overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking","volume":"4","author":"Pandey","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/ijms22010351","article-title":"Molecular mechanisms of treatment resistance in glioblastoma","volume":"22","author":"Ou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2012.01.013","article-title":"Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR","volume":"124","author":"Peng","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0105","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1046\/j.1471-4159.1994.62062099.x","article-title":"Cloning, characterization, and distribution of a mu-opioid receptor in rat brain","volume":"62","author":"Zastawny","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0110","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1046\/j.1471-4159.1998.70051819.x","article-title":"Evidence for kappa- and mu-opioid receptor expression in C6 glioma cells","volume":"70","author":"Bohn","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0090-9556(25)07655-X","article-title":"Studies of metabolic pathways of trimebutine by simultaneous administration of trimebutine and its deuterium-labeled metabolite","volume":"17","author":"Miura","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb1000","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458514526941","article-title":"PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis","volume":"20","author":"de Paula Faria","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nucmedbio.2024.108985_bb2000","doi-asserted-by":"crossref","first-page":"e0122363","DOI":"10.1371\/journal.pone.0122363","article-title":"A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox","volume":"10","author":"V\u00e1llez Garcia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb3000","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.neuroimage.2006.04.214","article-title":"A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI","volume":"32","author":"Schwarz","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.nucmedbio.2024.108985_bb4000","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","article-title":"PET radiotracers: crossing the blood-brain barrier and surviving metabolism","volume":"30","author":"Pike","year":"2009","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:03:32Z","timestamp":1746101012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":27,"alternative-id":["S0969805124001112"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108985","relation":{},"ISSN":["0969-8051"],"issn-type":[{"type":"print","value":"0969-8051"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET imaging of the anticancer drug candidate [11C]trimebutine in a rat glioma model","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108985"}}